Showing results (3171-3180 of 4,130) with videos related to
Sort By:
Pageof 413
Human Gene Therapy|March 17, 2007
Adenovirus-mediated gene transfer of human vascular endothelial growth factor-d induces transient angiogenic effects in mouse hind limb muscleIvana Kholová, Suvi Koota, Nina Kaskenpää, et al.Human Gene Therapy|September 30, 2006
Synthetic messenger RNA as a tool for gene therapyPeter M Rabinovich, Marina E Komarovskaya, Zhi-Jia Ye, et al.Human Gene Therapy|September 30, 2006
Intravenous delivery of anti-RhoA small interfering RNA loaded in nanoparticles of chitosan in mice: safety and efficacy in xenografted aggressive breast cancerJ-Y Pillé, H Li, E Blot, et al.Human Gene Therapy|November 17, 2006
Phase I, open-label, dose-escalating study of a genetically engineered herpes simplex virus, NV1020, in subjects with metastatic colorectal carcinoma to the liverNancy Kemeny, Karen Brown, Anne Covey, et al.Human Gene Therapy|December 22, 2006
Hybrid adeno-associated virus bearing nonhomologous inverted terminal repeats enhances dual-vector reconstruction of minigenes in vivoZiying Yan, Diana C M Lei-Butters, Yulong Zhang, et al.Human Gene Therapy|December 26, 2006
Rapid construction of small interfering RNA-expressing adenoviral vectors on the basis of direct cloning of short hairpin RNA-coding DNAsHiroyuki Mizuguchi, Naoko Funakoshi, Tetsuji Hosono, et al.Human Gene Therapy|July 31, 2007
Human adenovirus replicates in immunocompetent models of pancreatic cancer in Syrian hamstersSergia Bortolanza, Pilar Alzuguren, Maria Buñuales, et al.Human Gene Therapy|July 17, 2007
Survivin-driven and fiber-modified oncolytic adenovirus exhibits potent antitumor activity in established intracranial gliomaIlya V Ulasov, Zeng B Zhu, Matthew A Tyler, et al.Human Gene Therapy|September 1, 2006
Enhanced gene transfer efficiency in the murine striatum and an orthotopic glioblastoma tumor model, using AAV-7- and AAV-8-pseudotyped vectorsThomas C Harding, Peter J Dickinson, Byron N Roberts, et al.Human Gene Therapy|September 1, 2006
Safety in nonhuman primates of ocular AAV2-RPE65, a candidate treatment for blindness in Leber congenital amaurosisSamuel G Jacobson, Sanford L Boye, Tomas S Aleman, et al.Pageof 413